Consainsights logo
Reports > Life Sciences > Gastrointestinal Stents Market Report

Gastrointestinal Stents Market Size, Share, Industry Trends and Forecast to 2033

This report provides an in-depth analysis of the Gastrointestinal Stents market, covering various aspects such as market size, trends, and forecasts for the period of 2023 to 2033. Insights include regional breakdowns, industry analysis, and key players in the market.

Metric Value
Study Period 2023 - 2033
2023 Market Size $2.50 Billion
CAGR (2023-2033) 7.3%
2033 Market Size $5.16 Billion
Top Companies Boston Scientific Corporation, Medtronic plc, Cook Medical, Abbott Laboratories
Last Modified Date 15 Nov 2024

Gastrointestinal Stents Market Report (2023 - 2033)

Gastrointestinal Stents Market Overview

The gastrointestinal stents industry is characterized by continuous innovation, with leading manufacturers focusing on developing advanced stenting solutions to improve patient outcomes. The shift towards minimally invasive surgeries and outpatient care is transforming the market landscape. Moreover, regulatory advancements and a surge in healthcare spending across developing regions are expected to create ample opportunities for market entry. The competitive landscape is dominated by a mix of established players and emerging startups, all vying for market share through product launch strategies and strategic partnerships.

What is the Market Size & CAGR of Gastrointestinal Stents market in 2023?

In 2023, the global gastrointestinal stents market is valued at approximately $3.39 billion, with a projected Compound Annual Growth Rate (CAGR) of 7.5% through 2033. This growth can be attributed to the rising prevalence of digestive diseases and related disorders necessitating stent placements. Enhanced healthcare infrastructure and increasing awareness regarding gastrointestinal health are boosting market expansion. Additionally, innovation in stent design and materials is making procedures safer and more effective, further driving demand.

Gastrointestinal Stents Industry Analysis

The gastrointestinal stents industry is characterized by continuous innovation, with leading manufacturers focusing on developing advanced stenting solutions to improve patient outcomes. The shift towards minimally invasive surgeries and outpatient care is transforming the market landscape. Moreover, regulatory advancements and a surge in healthcare spending across developing regions are expected to create ample opportunities for market entry. The competitive landscape is dominated by a mix of established players and emerging startups, all vying for market share through product launch strategies and strategic partnerships.

Gastrointestinal Stents Market Segmentation and Scope

The gastrointestinal stents market is segmented based on material type, application, end-user, and endoscopic technique. Key segments include metal, plastic, and bioabsorbable stents, which cater to specific clinical scenarios. Applications range from esophageal stenting to biliary and duodenal stents, each addressing unique disorders. Hospitals and ambulatory surgical centers are prominent end-users, driven by their ability to deliver comprehensive surgical interventions. Understanding these segments allows stakeholders to identify niche market opportunities for enhanced growth.

Request a custom research report for industry.

Gastrointestinal Stents Market Analysis Report by Region

Europe Gastrointestinal Stents Market Report:

Europe's market is anticipated to grow from $0.66 billion in 2023 to $1.35 billion by 2033. The growth is supported by well-established healthcare systems, higher adoption of new technologies, and increasing preferences for minimally invasive surgical options.

Asia Pacific Gastrointestinal Stents Market Report:

In the Asia Pacific region, the gastrointestinal stents market is expected to grow from $0.55 billion in 2023 to $1.13 billion by 2033. The growth is propelled by increasing healthcare investments, rising awareness of minimally invasive procedures, and a growing elderly population facing various gastrointestinal ailments.

North America Gastrointestinal Stents Market Report:

North American gastrointestinal stents market will see substantial growth, increasing from $0.89 billion in 2023 to $1.85 billion in 2033. This is attributed to advanced healthcare systems, high prevalence of gastrointestinal disorders, and industry-leading innovations in stent designs and materials.

South America Gastrointestinal Stents Market Report:

The South American market is projected to expand from $0.16 billion in 2023 to $0.33 billion by 2033, driven by growing healthcare access and rising cases of gastrointestinal diseases, particularly in urban areas. Efforts by governments to improve healthcare facilities are also significantly impacting market growth.

Middle East & Africa Gastrointestinal Stents Market Report:

The Middle East and Africa region is forecasted to experience growth from $0.24 billion in 2023 to $0.50 billion by 2033. Factors contributing to this growth include rising healthcare expenditures, improving infrastructure, and increasing awareness of gastrointestinal health management.

Request a custom research report for industry.

Gastrointestinal Stents Market Analysis By End User

Global Gastrointestinal Stents Market, By End-User Market Analysis (2023 - 2033)

In terms of end-user segments, the hospitals dominate the gastrointestinal stents market, accounting for a market size of $1.72 billion in 2023, expected to grow to $3.54 billion by 2033. Hospitals contribute approximately 68.65% share in this segment. Clinics are gaining traction, expected to move from $0.58 billion in 2023 to $1.20 billion in 2033, holding a 23.24% market share. Ambulatory surgical centers, while smaller, show promising growth from $0.20 billion to $0.42 billion during the same period.

Gastrointestinal Stents Market Analysis By Material

Global Gastrointestinal Stents Market, By Material Market Analysis (2023 - 2033)

Metal stents, accounting for a market size of $1.72 billion in 2023, are forecasted to reach $3.54 billion in 2033 with an 68.65% market share. Plastic stents are also significant, moving from $0.58 billion to $1.20 billion, holding a 23.24% share. Bioabsorbable stents, while currently smaller, are expected to grow significantly, from $0.20 billion to $0.42 billion, representing an 8.11% market share.

Gastrointestinal Stents Market Analysis By Application

Global Gastrointestinal Stents Market, By Application Market Analysis (2023 - 2033)

The application segment sees esophageal stents leading with a market size of $1.38 billion in 2023, expanding to $2.85 billion by 2033, securing a 55.21% market share. Duodenal stents follow closely, growing from $0.56 billion to $1.16 billion with a 22.39% share. Colonic and biliary stents contribute to a combined market size of $0.56 billion in 2023, projected to double by 2033.

Gastrointestinal Stents Market Analysis By Endoscopic Technique

Global Gastrointestinal Stents Market, By Endoscopic Technique Market Analysis (2023 - 2033)

Esophageal endoscopy is a leading technique, holding a market size of $1.72 billion in 2023, anticipated to reach $3.54 billion by 2033, representing a market share of 68.65%. Duodenal endoscopy is also significant, growing from $0.58 billion to $1.20 billion, illustrating the increasing reliance on advanced diagnostic methods in gastrointestinal care.

Gastrointestinal Stents Market Trends and Future Forecast

Market trends indicate a robust growth trajectory through 2033, majorly driven by technological advancements and product innovations. Self-expandable stents are gaining popularity, attributed to their flexibility and ease of use. Moreover, the growing incidence of gastrointestinal cancers is expected to increase demand. The market also faces challenges such as regulatory hurdles and competition from alternative therapeutic methods. However, continuous innovations and increasing healthcare expenditure in emerging markets present promising growth opportunities.

Request a custom research report for industry.

Global Market Leaders and Top Companies in Gastrointestinal Stents Industry

Boston Scientific Corporation:

A leading manufacturer of medical devices with a strong portfolio in gastrointestinal stents, Boston Scientific focuses on innovative solutions enhancing patient care.

Medtronic plc:

Known for its broad range of surgical products, Medtronic is a key player in the gastrointestinal stent market, emphasizing advanced technologies and minimally invasive strategies.

Cook Medical:

Cook Medical provides a diverse selection of stenting solutions, contributing significantly to the market with its commitment to research and development.

Abbott Laboratories:

A global healthcare company, Abbott is recognized for its innovative stent products, benefiting from its extensive clinical trial portfolio and regulatory expertise.

We're grateful to work with incredible clients.

Datasite
Agilent
Asten Johnson
Bio-Rad
Carl Zeiss
Dywidag
Illumina
LEK Consulting
Shell

Related Industries

    FAQs